S

Structure Therapeutics Inc
NASDAQ:GPCR

Watchlist Manager
Structure Therapeutics Inc
NASDAQ:GPCR
Watchlist
Price: 24.65 USD 2.07% Market Closed
Market Cap: 1.4B USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+7%
Revenue
Forecast
N/A
Net Income
Forecast
N/A

Wall Street
Price Targets

GPCR Price Targets Summary
Structure Therapeutics Inc

Wall Street analysts forecast GPCR stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GPCR is 80.29 USD with a low forecast of 50.5 USD and a high forecast of 123.9 USD.

GPCR Lowest Forecast
Wall Street Target
50.5 USD
105% Upside
GPCR Average Forecast
Wall Street Target
80.29 USD
226% Upside
GPCR Highest Forecast
Wall Street Target
123.9 USD
403% Upside
Lowest
Price Target
50.5 USD
105% Upside
Average
Price Target
80.29 USD
226% Upside
Highest
Price Target
123.9 USD
403% Upside
Structure Therapeutics Inc Competitors:
Price Targets
ACB
Aurora Cannabis Inc
38% Upside
SAN
Sanofi SA
30% Upside
4151
Kyowa Kirin Co Ltd
24% Upside
4502
Takeda Pharmaceutical Co Ltd
23% Upside
ACB
Aurora Cannabis Inc
38% Upside
SAN
Sanofi SA
30% Upside
4151
Kyowa Kirin Co Ltd
24% Upside
4502
Takeda Pharmaceutical Co Ltd
23% Upside
688185
CanSino Biologics Inc
32% Upside
CORT
Corcept Therapeutics Inc
87% Upside
D
DPHARMA
Duopharma Biotech Bhd
18% Upside
G
512
Grand Pharmaceutical Group Ltd
21% Downside

Revenue
Forecast

Revenue Estimate
Structure Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Structure Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Structure Therapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-42%
Average Miss
What are analyst estimates?

See Also

Summary
GPCR intrinsic value, competitors valuation, and company profile.
DCF Valuation
GPCR stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GPCR stock valuation using valuation multiples.
Wall Street Estimates
GPCR price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GPCR stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GPCR's stock price target?
Price Target
80.29 USD

According to Wall Street analysts, the average 1-year price target for GPCR is 80.29 USD with a low forecast of 50.5 USD and a high forecast of 123.9 USD.

Back to Top
ALPHA SPREAD
Follow us
Join more than 256,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.